logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Antibodies cover

Antibodies

IF2.7
Papers625
Citations1965
Journal Papers 582
Publication Date
delete
Antibody-Related Mechanisms in Ocular Diseases: Autoimmunity, Malignancy, and Therapeutic Targeting
deleteAntibodies
IF2.7
delete2026-10-11
delete0
deleteOAAI
deleteYehan Xiao; Yaru Zou; Mingming Yang; Wendong Gu; Zizhen Ye; Jiaxin Deng; Kyoko Ohno-Matsui; Koju Kamoi
deleteShare
deleteSave
Head-to-Head Comparison of FAP Antibody Clones for Tissue Expression Analysis
deleteAntibodies
IF2.7
delete2026-10-10
delete0
deleteOAAI
deleteElena Shmakova; Anna Kalinchuk; Elisaveta Tsarenkova; Pavel Bazhenov; Vlada Vasilchuk; Dmitry Loos; Liubov Tashireva
deleteShare
deleteSave
Antibody Discovery and Therapeutics in Spondyloarthritis: Recent Advances and Future Directions
deleteAntibodies
IF2.7
delete2026-10-05
delete0
deleteOAAI
deleteKwai Wei Chan; Ghee Chong Koo; Che Kang Lim
deleteShare
deleteSave
Targeting the Complement C1 Proteases Using Camelid-Derived Single Domain Antibodies: Production, Characterization and Possible Application for Tissue/Fluid Analysis
deleteAntibodies
IF2.7
delete2026-10-05
delete0
deleteOAAI
deleteNolwenn Haut; Véronique Rossi; Julie Peliconi; Jean-Baptiste Reiser; Nicole M. Thielens; Lubka T. Roumenina; Christine Gaboriaud
deleteShare
deleteSave
Complement in HER2-Positive Breast Cancer: A Conditionally Protective Mechanism Under Attack
deleteAntibodies
IF2.7
delete2026-10-05
delete0
deleteOAAI
deleteDobromira Petkova; Ivaila Kuleva; Zhasmin Stoyanova; Boryana Ilcheva; Albena Fakirova; Zhasmina Mihaylova; Maria Radanova
deleteShare
deleteSave
Development and Validation of Novel VHHs Targeting Astrocyte-Enriched Glutamate Transporters GLT-1 and GLAST-1
deleteAntibodies
IF2.7
delete2026-09-29
delete0
deleteOAAI
deleteNoelia Gesteira-Pérez; Pieterjan Van Maele; Benedetta Frizzi; Ludo Van Den Bosch; Laura Rué; Maarten Dewilde
deleteShare
deleteSave
Endogenous Sex Hormones Explain Variation in Long-Term SARS-CoV-2 Antibody Persistence Beyond Biological Sex
deleteAntibodies
IF2.7
delete2026-09-22
delete0
deleteOAAI
deleteNicole Ivaska; Laura Rothschild
deleteShare
deleteSave
Multiple Modes of Action of Anti-TNF-α Antibodies for Inflammatory Bowel Diseases Beyond TNF-α Neutralization
deleteAntibodies
IF2.7
delete2026-09-21
delete0
deleteOAAI
deleteTomohiro Watanabe; Masatoshi Kudo
deleteShare
deleteSave
The Diagnostic and Clinical Significance of Anti-Mutated Citrullinated Vimentin Antibodies in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Scoping Review
deleteAntibodies
IF2.7
delete2026-09-21
delete0
deleteOAAI
deleteChristian D’Elia; Giada Santagata; Serena Guiducci; Holger Bang; Mariangela Manfredi; Maria Infantino; Maurizio Benucci
deleteShare
deleteSave
Antibodies Against SARS-CoV-2 Nucleocapsid Protein Possess Autoimmune Properties
deleteAntibodies
IF2.7
delete2026-09-21
delete0
deleteOAAI
deleteAlexandra Rak; Yana Zabrodskaya; Pei-Fong Wong; Irina Isakova-Sivak
deleteShare
deleteSave
Sera of Healthy First-Degree Relatives of SLE Patients Contain Autoantibodies to Globular Domains of C1q
deleteAntibodies
IF2.7
delete2026-09-21
delete0
deleteOAAI
deleteGinka Cholakova; Alexandra Atanasova; Alexandra Kapogianni; Dobroslav Kyurkchiev; Bogdan Penev; Ivanka Tsacheva
deleteShare
deleteSave
Targeted Therapy for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Critical Narrative Review and an Evidence-Graded Approach to Agent Selection
deleteAntibodies
IF2.7
delete2026-09-18
delete0
deleteOAAI
deleteLuca Guarino; Giuseppe Rizzuto; Vincenzo Coppolelli; Alessia Scipione; Mirella Scattone; Luca Gargano; Pietro Scribani Rossi; Ester Del Duca; Annunziata Dattola; Giovanni Pellacani; Steven Nisticò; Camilla Chello
deleteShare
deleteSave
B Cells and Tumor Immunometabolism: Emerging Insights into Immune Regulation and Therapeutic Resistance
deleteAntibodies
IF2.7
delete2026-09-18
delete0
deleteOAAI
deleteSwati Gupta; Sandip Rath; Surathi Maiti; Tapas Das; Farhat Afrin
deleteShare
deleteSave
Antibody-Based Biologics for CNS Disorders
deleteAntibodies
IF2.7
delete2026-09-17
delete0
deleteOAAI
deleteEric Ka-Wai Hui; Ruben J. Boado
deleteShare
deleteSave
Prevalence and Clinical Associations of Systemic Sclerosis-Related Autoantibodies: A Nationwide Reuma.pt Cohort Study
deleteAntibodies
IF2.7
delete2026-09-16
delete0
deleteOAAI
deleteCarolina Mazeda; Eduardo Dourado; Raquel Freitas; Patrícia Martins; Liliana Saraiva; Tânia Santiago; Francisca Guimarães; Emanuel Costa; Diogo Esperança Almeida; Sara Dinis; Ana Sofia Pinto; Alexandra Daniel; Inês Genrinho; Maura Couto; Marília Rodrigues; Maria João Salvador; Ana Catarina Duarte; Ana Cordeiro; Maria José Santos; João Eurico Fonseca; Catarina Resende; Inês Cordeiro
deleteShare
deleteSave
Molecular Architecture and Clinical Landscape of Immune Checkpoint Receptors and Ligands
deleteAntibodies
IF2.7
delete2026-09-10
delete0
deleteOAAI
deleteMilena Czosnek; Agata Sowa; Łucja Rolek; Ewelina Grywalska; Sebastian Mertowski; Paulina Mertowska
deleteShare
deleteSave
Ca16Mab-56, a Novel Anti-Cadherin-16/Ksp-Cadherin Monoclonal Antibody for Multiple Applications
deleteAntibodies
IF2.7
delete2026-09-08
delete0
deleteOAAI
deleteYukari Ogura; Hiroyuki Suzuki; Mika K. Kaneko; Yukinari Kato
deleteShare
deleteSave
Seroprevalence of IgG Antibodies to Measles, Mumps, Rubella and Varicella in Adolescents with Documented Two-Dose MMR Vaccination: Cross-Sectional Study
deleteAntibodies
IF2.7
delete2026-09-05
delete0
deleteOAAI
deleteMikhail P. Kostinov; Ivan S. Samolygo; Aristitsa M. Kostinova; Natalya L. Starikova; Marina A. Manina; Valentina B. Polishchuk; Albina S. Pestova; Pavel I. Zhuravlev; Anton S. Antishin; Svetlana I. Erdes
deleteShare
deleteSave
The Evolution of Artificial Intelligence in Antibody Design: From Structure-Based Engineering to Generative Models
deleteAntibodies
IF2.7
delete2026-09-03
delete0
deleteOAAI
deleteIda Szataniak; Kacper Packi
deleteShare
deleteSave
Clinical Characteristics and Risk Factors for Severe Immune-Related Liver Injury Following Nivolumab and Ipilimumab Combination Therapy
deleteAntibodies
IF2.7
delete2026-09-02
delete0
deleteOAAI
deleteYuichi Yamazaki; Satoru Kakizaki; Yuki Tamura; Yumeo Tateyama; Tatsuma Murakami; Takuya Adachi; Hiroki Tojima; Toshio Uraoka
deleteShare
deleteSave